Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

ENLV.US Logo

ENLV.US - Current Price

$0.89

Company Information

▼
Company Name
Enlivex Therapeutics Ltd
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: IL0011319527
CIK: 0000919794
CUSIP: M20156127
Currency: USD
Full Time Employees: 0
Phone: 972 2 620 8072
Website: https://www.enlivex.com
Fiscal Year End: December
IPO Date: Dec 12, 1995
Description:

Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat end-stage knee osteoarthritis; 0006-24-KMC, which is in phase I/II clinical trial for the treatment of Basal thumb osteoarthritis; and ENX-CL-06-001 to treat Psoriatic arthritis and is in phase I/II clinical trial. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Ness Ziona, Israel.

Address:

14 Einstein Street, Ness Ziona, Israel, 7403618

Directors & Officers

▼
Name Title Year Born
Mr. Shai Novik M.B.A. Executive Chairman 1966
Dr. Oren Hershkovitz Ph.D. Chief Executive Officer 1977
Prof. Dror Mevorach M.D. Founder & Scientific Advisor 1956
Ms. Shachar Shlosberger CPA Chief Financial Officer 1977
Dr. Veronique Amor-Baroukh Senior Director of Operations NA
Ms. Sigal Arad Director of Human Resources NA
Dr. Einat Galamidi M.D. Chief Medical Officer 1974

Shares Statistics

▼
Shares Outstanding: 237.38M
Shares Float: 17.28M
% Insiders: 46.30%
% Institutions: 41.10%
Short % Float: 0.26%

Valuation Metrics

▼
Enterprise Value: $208.65M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $226.15M
EBITDA: $-14.33M
Book Value: $0.72
Earnings/Share: $-0.54
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -36.02%
ROE (TTM): -57.64%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.14 N/A 10,000.00%
Sep 30, 2025 -0.09 -0.14 N/A 3,750.00%
Jun 30, 2025 -0.11 -0.15 N/A 2,619.52%
Mar 31, 2025 -0.15 -0.16 N/A 625.00%
Dec 31, 2024 -0.23 -0.16 N/A -4,375.00%
Sep 30, 2024 -0.16 -0.20 N/A 1,794.87%
Jun 30, 2024 -0.16 -0.15 N/A -666.67%
Mar 31, 2024 -0.22 -0.25 N/A 1,200.00%
Dec 31, 2023 -0.48 -0.28 N/A -7,142.86%
Sep 30, 2023 -0.32 -0.32 N/A 0.00%
Jun 30, 2023 -0.40 -0.46 N/A 1,304.35%
Mar 31, 2023 -0.39 -0.40 N/A 250.00%
Dec 31, 2022 -0.39 -0.38 N/A -263.16%
Sep 30, 2022 -0.31 -0.29 N/A -689.66%
Jun 30, 2022 -0.54 -0.45 N/A -2,000.00%
Mar 31, 2022 -0.45 -0.28 N/A -6,071.43%
Sep 30, 2021 -0.19 -0.21 N/A 952.38%
Jun 30, 2021 -0.17 -0.26 N/A 3,461.54%
Mar 31, 2021 -0.19 -0.21 N/A 952.38%
Dec 31, 2020 -0.25 -0.24 N/A -416.67%
Sep 30, 2020 -0.16 -0.18 N/A 1,111.11%
Jun 30, 2020 -0.23 -0.24 N/A 416.67%
Mar 31, 2020 -0.07 -0.24 N/A 7,083.33%
Dec 31, 2019 -0.25 -0.25 N/A 0.00%
Sep 30, 2019 -0.24 N/A N/A N/A
Jun 30, 2019 -0.16 N/A N/A N/A
Mar 31, 2019 -0.16 N/A N/A N/A
Dec 31, 2018 -0.16 0.00 N/A N/A
Sep 30, 2018 -0.12 0.00 N/A N/A
Jun 30, 2018 -0.50 0.00 N/A N/A
Mar 31, 2018 -2.34 0.00 N/A N/A
Dec 31, 2017 -0.16 N/A N/A N/A
Sep 30, 2017 -2.56 N/A N/A N/A
Jun 30, 2017 -4.00 N/A N/A N/A
Mar 31, 2017 -6.40 -11.60 N/A 4,482.76%
Dec 31, 2016 -7.60 -10.80 N/A 2,962.96%
Sep 30, 2016 -11.20 -8.80 N/A -2,727.27%
Jun 30, 2016 -8.80 -10.80 N/A 1,851.85%
Mar 31, 2016 -12.80 -11.40 N/A -1,228.07%
Dec 31, 2015 -13.60 -10.00 N/A -3,600.00%
Sep 30, 2015 -9.20 -11.60 N/A 2,068.97%
Jun 30, 2015 -10.40 -11.20 N/A 714.29%
Mar 31, 2015 -9.20 -9.80 N/A 612.24%
Dec 31, 2014 -8.80 -6.20 N/A -4,193.55%
Sep 30, 2014 -6.40 -3.40 N/A -8,823.53%
Jun 30, 2014 -4.04 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $3.30M $N/A $27.69M $4.10M $23.59M
2023-12-31 $813.00K $N/A $36.83M $6.75M $30.08M
2022-12-31 $47.82M $N/A $67.64M $10.80M $56.84M
2021-12-31 $11.20M $N/A $95.15M $10.11M $85.04M
2020-12-31 $5.67M $N/A $40.36M $4.87M $35.49M
2019-12-31 $3.95M $N/A $17.56M $6.28M $11.28M
2018-12-31 $9.74M $N/A $11.03M $1.33M $9.71M
2017-12-31 $3.53M $N/A $3.62M $460.00K $3.16M
2016-12-31 $6.87M $N/A $10.63M $1.93M $8.70M
2015-12-31 $7.29M $N/A $20.52M $2.58M $17.93M
2014-12-31 $10.58M $N/A $32.95M $2.28M $30.67M
2013-12-31 $5.55M $N/A $5.69M $131.00K $5.56M
2012-12-31 $146.00K $N/A $156.00K $81.00K $75.00K
2007-12-31 $6.93M $N/A $42.20M $14.11M $28.09M
2006-12-31 $4.15M $N/A $27.69M $7.53M $20.16M
2005-12-31 $6.44M $N/A $45.14M $9.27M $35.86M
2004-12-31 $5.96M $N/A $45.27M $10.03M $35.24M
2003-12-31 $8.53M $N/A $45.74M $18.17M $27.58M
2002-12-31 $10.68M $N/A $53.35M $14.71M $38.64M
2001-12-31 $8.35M $N/A $61.92M $9.18M $52.74M
2000-12-31 $13.32M $N/A $102.40M $6.06M $96.34M

Watchlist

0

No stocks in watchlist